Staging & restaging
Understanding how far disease has spread, at diagnosis or after treatment.
Oncology & Molecular Imaging
Oncology & Molecular Imaging in Gurugram.
Molecular imaging to support cancer care decisions.
PET-CT studies for staging, treatment response and follow-up, using FDG and receptor-targeted tracers, reported by a nuclear medicine physician.
With Dr. Noaline Sinha, Nuclear Medicine & Radiotheranostics.
Artemis Hospital, Sector 51, Gurugram
About Oncology Imaging
How disease behaves,not just where it is.
Oncology PET-CT combines functional information from PET with anatomical detail from CT in a single study. Depending on your clinical question, the tracer is chosen to look at glucose metabolism or at specific receptors found on certain tumours.
Metabolic imaging
FDG PET-CT shows how active tissues are, which helps in staging, assessing treatment response and surveillance across many cancers.
Receptor-targeted imaging
Tracers such as DOTATATE, PSMA and FAPI target specific receptors, which helps in neuroendocrine tumours, prostate cancer and other selected conditions.
Your doctor will advise which study is appropriate for your clinical question.
Have a question?
Share your details and our team will get in touch.
Studies Included
Studies offered.
Tracers are chosen to match the clinical question. This list is provided for patients and for referring clinicians.
Oncology & Molecular Imaging
10 studies
- ¹⁸F-FDG Whole-Body PET-CTOncology staging, restaging, treatment response assessment and surveillance
- ⁶⁸Ga-DOTANOC / DOTATATE PET-CTNeuroendocrine tumours and other somatostatin receptor-expressing lesions
- ⁶⁸Ga-PSMA PET-CTProstate cancer imaging
- ¹⁸F-PSMA PET-CTProstate cancer imaging
- ¹⁸F-FDOPA PET-CTNeuroendocrine and selected neurological indications
- ⁶⁸Ga-FAPI PET-CTFibroblast activation protein imaging
- ¹⁸F-FES PET-CTOestrogen receptor imaging in ER-positive breast carcinoma
- ⁶⁸Ga-Exendin PET-CTLocalisation of insulinoma
- ⁶⁸Ga-Pentixafor PET-CTCXCR4 receptor imaging
- ⁶⁸Ga-Trivehexin PET-CTIntegrin αvβ6 imaging in selected malignancies, including head and neck squamous cell carcinoma and pancreatic carcinoma
When It May Help
Supporting decisions across your cancer care.
Your treating doctor recommends imaging based on your clinical needs.
Treatment response & surveillance
Reviewing how disease has responded to treatment and keeping watch during follow-up.
Receptor imaging
Neuroendocrine tumours, prostate cancer and other receptor-expressing disease with DOTATATE, PSMA and FAPI tracers.
Planning targeted therapy
Helping your team decide whether a receptor-targeted treatment may be suitable.
Your Visit, Step by Step
Know what to expect. Feel more prepared.
What happens during a PET-CT visit.
- 01
Check-in & review
The team reviews your referral and relevant medical history.
- 02
Tracer & rest
A tracer is administered, followed by a resting period.
- 03
Your scan
You lie on the scanner table while images are acquired.
- 04
After your visit
The team explains the next steps and reporting process.
The exact process depends on your scan and clinical needs.
Before Your Visit
Preparing for your scan.Simple steps.
What to discuss with the team
Your referral & previous reports
Bring the referral, histology and earlier scan reports and images where available.
Diabetes & medicines
Tell the team about diabetes, insulin and other medicines. FDG scans in particular depend on well-controlled blood sugar.
Fasting & hydration
Fasting needs differ by tracer, so follow the instructions given for your scan.
Recent treatment
Mention recent surgery, chemotherapy, radiotherapy or biopsies, as the timing can affect how images are read.
Pregnancy, breastfeeding & allergies
Let the team know before your appointment.
Guidance tailored to you
Preparation varies by tracer and by scan. Contact the team if you are unsure about any instruction.
For Referring Clinicians
Referring a patient to our team.
A short guide for referring doctors.
- 1
What to include
The clinical question, relevant history, biochemistry or histology where available, and previous imaging reports.
- 2
Choosing the study
The studies listed on this page are chosen to match the clinical question. If you are unsure which is most appropriate, we are happy to help.
- 3
Reporting
Studies are reported by a nuclear medicine physician, and findings can be discussed with the referring team.
- 4
Discussing a case first
Call or write before referring if you would like to discuss suitability or timing.
Questions before you refer? Contact Dr. Sinha directly.
Your consultant
ConsultDr. Noaline Sinha.
Chairperson of the Department of Nuclear Medicine & Radiotheranostics, with over 25 years in molecular imaging and radionuclide therapy.
Experience
Over 25 years in nuclear medicine, leading the Department of Nuclear Medicine & Radiotheranostics.
Radiation safety
Certified Radiation Safety Officer (RSO-II) by the Atomic Energy Regulatory Board.
Collaborative practice
Works alongside referring and treating clinicians on every case.
Dr. Noaline Sinha
Chairperson, Nuclear Medicine & Radiotheranostics
FAQs
Common questionsabout oncology imaging.
Answers to questions patients often ask before an oncology scan.
Still have questions?Speak to our team for guidance before your visit.
Your doctor recommends the study based on your clinical question. FDG is used for many cancers, while receptor-targeted tracers such as DOTATATE, PSMA and FAPI are used for specific conditions. The team can discuss suitability with you before you book.
Fasting instructions depend on the tracer and your scan. Follow the guidance given when your appointment is arranged.
It can, because FDG behaves like sugar in the body. Tell the team about diabetes and your medicines so they can advise you on preparation.
The time varies by tracer and scan. The team will tell you what to expect when arranging your appointment.
PET-CT uses a small amount of radioactivity and the team follows radiation safety practices. Tell the team if you are pregnant or breastfeeding.
Your referring doctor will usually discuss the findings with you. Contact the team about when your report will be available.
More Services
Explore our other services.
Imaging and therapy services offered by the department.
Neurological PET-CT
Cardiac PET-CT
Infection, Inflammation & Skeletal Imaging- Cardiac Nuclear Medicine
- Neurological Imaging
Skeletal Imaging
Renal & Genitourinary Imaging
Hepatobiliary & Gastrointestinal Imaging
Endocrine Imaging
Pulmonary Imaging- Infection, Lymphatic & Other Imaging
- Radioiodine Therapy
Peptide Receptor Radionuclide Therapy (PRRT)
Prostate Cancer Theranostics
Other Targeted Radionuclide Therapies
Therapy Planning, Imaging & Dosimetry
Request an Appointment
Fill in your details and our team will get back to you to confirm your appointment.
Take the Next Step
Let’s Begin Your Journey to Better Care.
Reach out to schedule a personalised consultation or speak with our team. We’re here to guide you with clarity, compassion, and expert care — every step of the way.
Book a Consultation
Schedule a personalised consultation with Dr. Noaline Sinha at your convenience.
Talk to Our Team
Have questions? Our care team is here to help you with guidance and information.
Consult in Gurugram
Consultations are held in person in Gurugram. The team will confirm the details with you.